Growth Metrics

Mirum Pharmaceuticals (MIRM) Change in Intangibles (2023 - 2026)

Mirum Pharmaceuticals' quarterly Change in Intangibles came in at $10.0 million in Q1 2026, little changed quarter-over-quarter from $10.0 million in Q3 2024.

Mirum Pharmaceuticals has reported Change in Intangibles for 3 years, with the latest figure at $10.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Intangibles changed N/A year-over-year to $10.0 million; the trailing twelve-month figure through Mar 2026 stood at $10.0 million (down 50.0% YoY), and the FY2024 full-year result was $20.0 million, changed 0.0% from the prior year.
  • Change in Intangibles for Q1 2026 stood at $10.0 million, roughly flat from $10.0 million in the prior quarter.
  • The five-year high for Change in Intangibles was $15.0 million in Q1 2023, with the low at $5.0 million in Q4 2023.
  • Average Change in Intangibles over 3 years is $10.0 million, with a median of $10.0 million recorded in 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 68,980.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -
10 Mirum Pharmaceuticals 5.97 Bn 5.59 Bn 131.08 Mn 10.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.00 Mn
Mar 31, 2026 10.00 Mn
Sep 30, 2024 10.00 Mn
Sep 30, 2024 10.00 Mn
Jun 30, 2024 10.00 Mn
Jun 30, 2024 10.00 Mn
Dec 31, 2023 5.00 Mn
Dec 31, 2023 5.00 Mn
Mar 31, 2023 15.00 Mn
Mar 31, 2023 15.00 Mn